Home › SEC Filings › Press Releases
Press Releases
All Current Report (8-K)Annual Report (10-K)Quarterly Report (10-Q)Form 4 Insider TradesSC 13D Beneficial Ownership13F Institutional HoldingsPress ReleasesInsider Cluster ActivityInsider Buy Activity
Theme?
All themes Artificial IntelligenceSemiconductorsQuantum ComputingSpace & SatellitesRobotics & AutomationElectric VehiclesClean & Renewable EnergyBattery & Energy StorageNuclear & FusionCybersecurityCloud & SaaSFintech & PaymentsCrypto & BlockchainGenomics & Gene EditingBiotech & Drug DiscoveryE-commerce & PlatformsStreaming & Digital MediaGaming & EsportsDefense TechCannabis
| Ticker | Type | Sentiment | Impact | Summary | Date |
|---|---|---|---|---|---|
| WBD | PRESS-RELEASE | bullish | 7/10 | The European Commission unconditionally approved Paramount Skydance Corporation's (PSKY) acquisition of Warner Bros. Dis | Jul 22, 2026 |
| SHW | PRESS-RELEASE | neutral | 2/10 | Sherwin-Williams declared a regular quarterly dividend of $0.80 per share, payable September 11, 2026. This is a routine | Jul 22, 2026 |
| CHRS | PRESS-RELEASE | neutral | 1/10 | Coherus Oncology, Inc. announced it will report its Q2 2026 results on August 5, 2026. | Jul 22, 2026 |
| APD | PRESS-RELEASE | neutral | 2/10 | Air Products declared a quarterly dividend of $1.81 per share, payable November 9, 2026 to shareholders of record on Oct | Jul 22, 2026 |
| QTEX | PRESS-RELEASE | mixed | 5/10 | QTREX Quantum issued a press release clarifying that its July 21 Form F-1 filing is a resale registration for pre-existi | Jul 22, 2026 |
| OKYO | PRESS-RELEASE | bullish | 4/10 | OKYO Pharma Chairman Gabriele Cerrone, through Panetta Partners Ltd, purchased 22,500 ordinary shares at $1.45 per share | Jul 22, 2026 |
| WEC | PRESS-RELEASE | neutral | 1/10 | WEC Energy Group announced it will report its Q2 2026 results on July 29. | Jul 22, 2026 |
| LLY | PRESS-RELEASE | neutral | 1/10 | Eli Lilly and Company announced it will host a conference call on August 5, 2026 to discuss its Q2 2026 results. | Jul 22, 2026 |
| NWFL | PRESS-RELEASE | mixed | 6/10 | Norwood Financial Corp reported Q2 2026 net income of $9.3M (up 50% YoY) and diluted EPS of $0.86, in line with consensu | Jul 22, 2026 |
| ZM | PRESS-RELEASE | neutral | 5/10 | Zoom Communications reported Q1 FY2027 EPS of $1.55, a 5.1% beat vs $1.48 consensus, on revenue of $1.27B (in line with | Jul 22, 2026 |
| LION | PRESS-RELEASE | neutral | 1/10 | Lionsgate announced it will report its fiscal Q1 2027 results on August 6. | Jul 22, 2026 |
| HTCO | PRESS-RELEASE | bullish | 6/10 | HTCO reported a 38.3% revenue surge to $137.5M for H1 FY2026, driven by expanded dry bulk operations and a strategic piv | Jul 22, 2026 |
| PFBC | PRESS-RELEASE | bullish | 6/10 | Preferred Bank (PFBC) reported Q2 2026 diluted EPS of $2.78, beating the $2.65 consensus by 4.9%, while total revenue of | Jul 22, 2026 |
| PCRX | PRESS-RELEASE | neutral | 1/10 | Pacira BioSciences announced it will report its Q2 2026 results on August 4, 2026. | Jul 22, 2026 |
| MNPR | PRESS-RELEASE | bullish | 7/10 | Monopar Therapeutics initiated a rolling NDA submission to the FDA for ALXN1840 (tiomolibdate choline), a first-in-class | Jul 22, 2026 |
| LBRX | PRESS-RELEASE | bullish | 6/10 | LB Pharmaceuticals announced that its pivotal Phase 3 NOVA-2 trial of LB-102 in schizophrenia is enrolling faster than e | Jul 22, 2026 |
| TRU | PRESS-RELEASE | neutral | 2/10 | TransUnion released its Q2 2026 Canada Consumer Pulse Study, a survey on Canadian household financial sentiment and beha | Jul 22, 2026 |
| RGEN | PRESS-RELEASE | bullish | 7/10 | Repligen acquires BioLife Solutions for $1.5B (64% stock, 36% cash), paying $31.00/share, a 24% premium to the 90-day VW | Jul 22, 2026 |
| IQMX | PRESS-RELEASE | neutral | 1/10 | IQM Quantum Computers Oyj announced it will report its Q2 2026 results on August 4, 2026. | Jul 22, 2026 |
| GNTA | PRESS-RELEASE | neutral | 4/10 | Genenta Science (GNTA) reported FY2025 results for its 19%-owned affiliate Sòphia HT, showing 29.3% sales growth to €7.1 | Jul 22, 2026 |
| VVY | PRESS-RELEASE | neutral | 1/10 | Vivoryon Therapeutics N.V. announced it will report its full-year 2026 results on August 6, 2026. | Jul 22, 2026 |
| DYN | PRESS-RELEASE | bearish | 6/10 | Dyne Therapeutics priced an upsized underwritten public offering of 18.3 million shares at $20.50 per share, raising gro | Jul 21, 2026 |
| AIRJ | PRESS-RELEASE | bullish | 6/10 | AirJoule Technologies announced an initial deployment and exclusive sales agreement with Kubota Corporation for its wate | Jul 21, 2026 |
| NSC | PRESS-RELEASE | neutral | 2/10 | Norfolk Southern declared a quarterly dividend of $1.35 per share, payable August 20, 2026, to shareholders of record on | Jul 21, 2026 |
| TOP | PRESS-RELEASE | bearish | 7/10 | TOP Financial Group announced that all outstanding warrants to purchase up to 428,862,444 Class A ordinary shares were e | Jul 21, 2026 |
| BIP | PRESS-RELEASE | neutral | 5/10 | Brookfield Infrastructure Partners (BIP) and Brookfield Infrastructure Corporation (BIPC) announced a plan to simplify t | Jul 21, 2026 |
| BEP | PRESS-RELEASE | bullish | 6/10 | Brookfield Renewable announced plans to simplify its corporate structure by converting BEP (limited partnership) and BEP | Jul 21, 2026 |
| FULT | PRESS-RELEASE | neutral | 2/10 | Fulton Financial Corporation announced the appointment of David S. Schulz to its board of directors, effective September | Jul 21, 2026 |
| ACRE | PRESS-RELEASE | neutral | 1/10 | Ares Commercial Real Estate Corporation announced it will report its Q2 2026 results on August 4, 2026. | Jul 21, 2026 |
| EQT | PRESS-RELEASE | mixed | 6/10 | EQT reported Q2 2026 GAAP EPS of $0.34, missing the $0.42 consensus by 19%, and GAAP revenue of $1.81B, missing the $1.8 | Jul 21, 2026 |